Shares of Futura Medical plc (LON:FUM – Get Free Report) traded down 12.7% during mid-day trading on Wednesday . The company traded as low as GBX 9.75 ($0.13) and last traded at GBX 10 ($0.13). 1,345,431 shares traded hands during mid-day trading, an increase of 81% from the average session volume of 744,808 shares. The stock had previously closed at GBX 11.45 ($0.15).
Futura Medical Stock Performance
The company has a market cap of £31.17 million, a PE ratio of -8.25 and a beta of 1.25. The stock has a 50 day moving average of GBX 19.21 and a 200-day moving average of GBX 29.19.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Further Reading
- Five stocks we like better than Futura Medical
- Why Invest in High-Yield Dividend Stocks?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Short Selling: How to Short a Stock
- 3 Must-Own Stocks to Build Wealth This Decade
- What is Put Option Volume?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
